• Exchange: Indonesia
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kalbe Farma Tbk PT

+ Add to Watchlist

KLBF:IJ

1,680 IDR 20 1.20%

As of 05:13:42 ET on 09/01/2014.

Snapshot for Kalbe Farma Tbk PT (KLBF)

Open: 1,660 Day's Range: 1,660 - 1,680 Volume: 23,572,400
Previous Close: 1,660 52wk Range: 1,160 - 1,800 1-Yr Rtn: +25.77%

Stock Chart for KLBF

No chart data available.
  • KLBF:IJ 1,680
  • 1D
  • 1M
  • 1Y
1,660
Interactive KLBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KLBF

Current P/E Ratio (ttm) 39.1216
Estimated P/E(12/2014) 35.6302
Relative P/E vs. JCI 1.9074
Earnings Per Share (IDR) (ttm) 42.9430
Est. EPS (IDR) (12/2014) 47.1510
Est. PEG Ratio 3.1091
Market Cap (M IDR) 78,750,205.14
Shares Outstanding (M) 46,875.12
30 Day Average Volume 75,080,280
Price/Book (mrq) 9.4835
Price/Sale (ttm) 4.6431
Dividend Indicated Gross Yield 1.01%
Cash Dividend (IDR) 17.0000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 46.72%
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KLBF

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for KLBF

PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.

Johannes SetijonoPresident CommissionerBernadette Ruth Irawaty SetiadyPresident Director
Budi Dharma WreksoatmodjoVice President DirectorVidjongtius VidjongtiusCFO/Director/Secretary
More Company Profile & Key Executives for KLBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil